Cerebral amyloid angiopathy (CAA) is one of the major types of cerebral small vessel disease, and a leading cause of spontaneous intracerebral hemorrhage and cognitive decline in elderly patients. Although increasingly detected, a number of aspects including the pathophysiology, the clinical and neuroradiological phenotype, and the disease course are still under investigation. The incomplete knowledge of the disease limits the implementation of evidence-based guidelines on patient’s clinical management and the development of treatments able to prevent or reduce disease progression. The SENECA (SEarchiNg biomarkErs of Cerebral Angiopathy) project is the first Italian multicenter cohort study aimed at better defining the disease natural history and identifying clinical and neuroradiological markers of disease progression. By a multidisciplinary approach and the collection of a large and well-phenotyped series and biorepository of CAA patients, the study is ultimately expected to improve the diagnosis and the knowledge of CAA pathophysiological mechanisms.

Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA) : the SENECA project / A. Bersano, E. Scelzo, L. Pantoni, A. Morotti, A. Erbetta, L. Chiapparini, P. Vitali, G. Giaccone, P. Caroppo, M. Catania, L. Obici, G. Di Fede, L. Gatti, F. Tinelli, J.C. Di Francesco, F. Piazza, C. Ferrarese, M. Gasparini, L. Adobbati, S. Bianchi-Marzoli, G. Tremolada, S. Sacco, M. Mancuso, M.L. Zedde, M. Godani, S. Lanfranconi, D. Pareyson, M. Di Girolamo, C. Motto, A. Charidimou, G. Boulouis, E.A. Parati. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 41:8(2020 Aug), pp. 2193-2200. [10.1007/s10072-020-04306-8]

Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA) : the SENECA project

E. Scelzo;L. Pantoni;P. Vitali;S. Lanfranconi;
2020

Abstract

Cerebral amyloid angiopathy (CAA) is one of the major types of cerebral small vessel disease, and a leading cause of spontaneous intracerebral hemorrhage and cognitive decline in elderly patients. Although increasingly detected, a number of aspects including the pathophysiology, the clinical and neuroradiological phenotype, and the disease course are still under investigation. The incomplete knowledge of the disease limits the implementation of evidence-based guidelines on patient’s clinical management and the development of treatments able to prevent or reduce disease progression. The SENECA (SEarchiNg biomarkErs of Cerebral Angiopathy) project is the first Italian multicenter cohort study aimed at better defining the disease natural history and identifying clinical and neuroradiological markers of disease progression. By a multidisciplinary approach and the collection of a large and well-phenotyped series and biorepository of CAA patients, the study is ultimately expected to improve the diagnosis and the knowledge of CAA pathophysiological mechanisms.
Biomarkers; Cerebral amyloid angiopathy; Cortical superficial siderosis; Dementia; Intracerebral hemorrhage; Microbleeds; Neuroimaging; Small vessel disease
Settore MED/26 - Neurologia
ago-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
Bersano SENECA metodologico_Neurol Sci 2020_final.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 330.91 kB
Formato Adobe PDF
330.91 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/759910
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact